학술논문
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. (Irritable Bowel Syndrome)
Document Type
Product/service evaluation
Author
Source
Gut. May, 2003, Vol. 52 Issue 5, p671, 6 p.
Subject
Language
English
ISSN
0017-5749
Abstract
Background: Tegaserod has been shown to be an effective therapy for the multiple symptoms of irritable bowel syndrome (IBS) in Western populations. However, little information is available regarding the use [...]